These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8791028

  • 1. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD.
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract] [Full Text] [Related]

  • 2. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB, Stewart WF.
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical effectiveness of 311C90 in the acute treatment of migraine.
    Ferrari MD.
    Eur Neurol; 1996 Oct; 36 Suppl 2():4-7. PubMed ID: 8791025
    [Abstract] [Full Text] [Related]

  • 10. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V, Kazarawa Z, Fritsche G, Diener HC.
    Lancet; 1999 Jan 30; 353(9150):378. PubMed ID: 9950449
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical safety of 311C90: aggregated data from patients and volunteers to date.
    Earl NL.
    Eur Neurol; 1996 Jan 30; 36 Suppl 2():8-12. PubMed ID: 8791026
    [Abstract] [Full Text] [Related]

  • 13. A triptan too far?
    Goadsby PJ.
    J Neurol Neurosurg Psychiatry; 1998 Feb 30; 64(2):143-7. PubMed ID: 9489518
    [No Abstract] [Full Text] [Related]

  • 14. Increasing the options for effective migraine management.
    Goadsby PJ, Olesen J.
    Neurology; 1997 Mar 30; 48(3 Suppl 3):S1-3. PubMed ID: 9071262
    [No Abstract] [Full Text] [Related]

  • 15. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P.
    Cephalalgia; 1997 Oct 30; 17 Suppl 18():21-7. PubMed ID: 9399014
    [Abstract] [Full Text] [Related]

  • 16. Zolmitriptan receives migraine indication.
    Am J Health Syst Pharm; 1998 Jan 15; 55(2):110, 113. PubMed ID: 9465973
    [No Abstract] [Full Text] [Related]

  • 17. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR.
    Cephalalgia; 1997 Oct 15; 17 Suppl 18():4-14. PubMed ID: 9399012
    [Abstract] [Full Text] [Related]

  • 18. Attacking migraine headache from beginning to end.
    Moskowitz MA, Cutrer FM.
    Neurology; 1997 Nov 15; 49(5):1193-5. PubMed ID: 9371890
    [No Abstract] [Full Text] [Related]

  • 19. [Zolmitriptan].
    Le Jeunne C.
    Presse Med; 1999 Sep 25; 28(28):1525-6. PubMed ID: 10526561
    [No Abstract] [Full Text] [Related]

  • 20. [Zolmitriptan].
    Monseu G, Sternon J.
    Rev Med Brux; 1998 Dec 25; 19(6):495-9. PubMed ID: 9916496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.